Cangrelor Use Since FDA Approval A Single-Center, Real-World Experience at a Tertiary Care Hospital

被引：23
|
作者：
Vaduganathan, Muthiah [1 ]
Qamar, Arman [1 ]
Singh, Abhayjit [1 ]
Venkateswaran, Ramkumar V. [1 ]
Szumita, Paul M. [1 ]
Croce, Kevin J. [1 ]
Mauri, Laura [1 ]
Leopold, Jane A. [1 ]
Shah, Pinak B. [1 ]
Sobieszczyk, Piotr [1 ]
Faxon, David P. [1 ]
Bhatt, Deepak L. [1 ]
机构：
[1] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 04期
关键词：
D O I：
10.1016/j.jacc.2016.11.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：463 / 464
页数：2
相关论文
共 50 条
  • [1] Cangrelor Use in Cardiogenic Shock A Single-Center Real-World Experience
    Vaduganathan, Muthiah
    Qamar, Arman
    Badreldin, Hisham A.
    Faxon, David P.
    Bhatt, Deepak L.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (16) : 1712 - 1714
  • [2] Idarucizumab since FDA approval: Use in the real-world
    Ebinger, Joseph
    Granger, Christopher B.
    Zhu, Alexander
    Chang, Allison
    Henry, Timothy D.
    AMERICAN HEART JOURNAL, 2017, 193 : 93 - 94
  • [3] REAL-WORLD EXPERIENCE FOR BIOLOGIC USE IN IBD IN THAI: A SINGLE-CENTER EXPERIENCE
    Limsrivilai, Julajak
    Chaemsupaphan, Thanaboon
    Sattayalertyanyong, Onuma
    Subdee, Nichcha
    Permpim, Parinya
    Pausawasdi, Nonthalee
    GASTROENTEROLOGY, 2023, 164 (04) : S69 - S69
  • [4] Real-world use of PCSK9 inhibitors: A single-center experience
    Sarsam, Sinan
    Berry, Abeer
    Degheim, George
    Singh, Robby
    Zughaib, Marcel
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (01) : 265 - 270
  • [5] The AneuRx stent-graft since FDA approval: Single-center experience of 230 cases
    Ramaiah, VG
    Westerband, A
    Thompson, C
    Ravi, R
    Rodriguez, JA
    DiMugno, L
    Shafique, S
    Olsen, D
    Diethrich, EB
    JOURNAL OF ENDOVASCULAR THERAPY, 2002, 9 (04) : 464 - 469
  • [6] Real World Use of IDH2-Targeted Inhibitors in a Single Academic Medical Center Experience Since Enasidenib FDA-Approval
    Gales, Jordan
    McKinney, Matthew S.
    Erba, Harry P.
    McCall, Chad M.
    BLOOD, 2019, 134
  • [7] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Marwan Sheikh-Taha
    American Journal of Cardiovascular Drugs, 2019, 19 : 59 - 64
  • [8] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Sheikh-Taha, Marwan
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (01) : 59 - 64
  • [9] The Clinic Ottakring - Lipid Registry: a Contemporary Single-Center Real-World Analysis from a Tertiary Hospital
    Weltler, Patrick
    Pogran, Edita
    Harbich, Paul Felix
    Burger, Achim
    Neubauer, Georg
    Huber, Kurt
    CIRCULATION, 2024, 150
  • [10] Real-World Experience Using Emicizumab Prophylaxis for Hemophilia a: Single-Center Experience
    Vagrecha, Anshul
    Stanco, Joseph
    Ulus, Daphenee
    Acharya, Suchitra
    BLOOD, 2020, 136
12345